Activation of the plasma kallikrein/kinin system on endothelial cell membranes.
暂无分享,去创建一个
[1] M. Johnstone,et al. Platelet-Bound Prekallikrein Promotes Pro-Urokinase-Induced Clot Lysis: A Mechanism for Targeting the Factor XII Dependent Intrinsic Pathway of Fibrinolysis , 1994, Thrombosis and Haemostasis.
[2] R. Mandle,et al. An HMG-I protein from human endothelial cells apparently is secreted and impairs activation of Hageman factor (factor XII). , 1998, Proceedings of the Association of American Physicians.
[3] M. Silverberg,et al. Autoactivatability of human Hageman factor (factor XII). , 1980, Biochemical and biophysical research communications.
[4] A. Prasad,et al. Zinc in plasma, neutrophils, lymphocytes, and erythrocytes as determined by flameless atomic absorption spectrophotometry. , 1982, Clinical chemistry.
[5] D. Vaughan,et al. Selective Stimulation of Tissue-Type Plasminogen Activator (t-PA) In Vivo by Infusion of Bradykinin , 1997, Thrombosis and Haemostasis.
[6] R. Gorodetsky,et al. Packaging zinc, fibrinogen, and factor XIII in platelet α‐granules , 1993 .
[7] J. Henkin,et al. Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase Receptor (*) , 1995, The Journal of Biological Chemistry.
[8] A. Schmaier,et al. The expression of high molecular weight kininogen on human umbilical vein endothelial cells. , 1988, The Journal of biological chemistry.
[9] V. Gurewich,et al. Pro‐urokinase and prekallikrein are both associated with platelets , 1993, FEBS letters.
[10] M. Rocha e Silva,et al. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. , 1949, The American journal of physiology.
[11] R. Colman,et al. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc‐dependent binding to an anionic surface , 1992, Protein science : a publication of the Protein Society.
[12] H. Saito. Contact Factors in Health and Disease , 1987, Seminars in thrombosis and hemostasis.
[13] N. Ziats,et al. Inhibition of the activation of Hageman factor (factor XII) by human vascular endothelial cell culture supernates. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[14] E. Peerschke,et al. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Dunn,et al. Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. , 1980, The Journal of biological chemistry.
[16] A. Schmaier,et al. Factor XII Does not Initiate Prekallikrein Activation on Endothelial Cells , 1998, Thrombosis and Haemostasis.
[17] A. Retzios,et al. Effects of chemical modifications on the surface- and protein-binding properties of the light chain of human high molecular weight kininogen. , 1987, The Journal of biological chemistry.
[18] C. Cochrane,et al. The autoactivation of rabbit hageman factor , 1979, The Journal of experimental medicine.
[19] S. Reddigari,et al. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. , 1993, The Journal of biological chemistry.
[20] V. Donaldson,et al. Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[21] A. Schmaier,et al. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. , 1997, Blood.
[22] M. Gilbert,et al. Tissue plasminogen activator release in vivo in response to vasoactive agents. , 1985 .
[23] V. Gurewich,et al. Assembly and Activation of the Intrinsic Fibrinolytic Pathway on the Surface of Human Endothelial Cells in Culture , 1995, Thrombosis and Haemostasis.
[24] K. Fujikawa,et al. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. , 1986, The Journal of biological chemistry.
[25] I. Schousboe,et al. Partial identification of the Zn2+-binding sites in factor XII and its activation derivatives. , 1997, European journal of biochemistry.
[26] S. Iwanaga,et al. Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein. , 1987, Journal of biochemistry.
[27] E. Davie,et al. Waterfall Sequence for Intrinsic Blood Clotting , 1964, Science.
[28] I. Schousboe,et al. The surface-dependent autoactivation mechanism of factor XII. , 1997, European journal of biochemistry.
[29] A. Schmaier,et al. Bradykinin regulates the expression of kininogen binding sites on endothelial cells. , 1993, Blood.
[30] R. Gorodetsky,et al. Platelet multielemental composition, lability, and subcellular localization , 1993, American journal of hematology.
[31] A. Schmaier,et al. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. , 1991, The Journal of biological chemistry.
[32] J. Griffin,et al. A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen. , 1983, Thrombosis research.
[33] R. Schein,et al. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis. , 1988, The Journal of laboratory and clinical medicine.
[34] A. Schmaier,et al. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. , 1992, Blood.
[35] A. Schmaier,et al. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. , 1998, Blood.
[36] H. Büller,et al. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo. , 1991, The Journal of clinical investigation.
[37] P. D. de Groot,et al. The binding of high molecular weight kininogen to cultured human endothelial cells. , 1988, The Journal of biological chemistry.
[38] A. Schmaier,et al. Activation of the plasma kallikrein/kinin system on endothelial cells. , 1999, Proceedings of the Association of American Physicians.